Genetic Analysis AS

Genetic Analysis AS (GA) is positioned to become a world leader in the field of molecular in vitro diagnostics for diseases associated with gut imbalance. Based on the patented DNA-based GA map® platform technology, it can quickly generate a profile of a patient's gut microbiota and correlate it with various health conditions. Our first product, the GA map® Dysbiosis Test, assists gastroenterologists in measuring and monitoring the gut microbiota status of patients with irritable bowel syndrome (IBS).Further clinical application areas of this test include diagnosis, disease severity, IBS (irritable bowel syndrome), and inflammatory bowel disease (IBD) diagnosis, disease severity, treatment prediction, and monitoring, which require clinical data and validation.